BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36720670)

  • 1. Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19.
    Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2023 Apr; 56(2):236-245. PubMed ID: 36720670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
    Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
    Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Laboratory Characteristics of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children.
    Phi DL; Dao TL; To MM; Nguyen TB; Nguyen DC; Gautret P; Hoang VT
    J Korean Med Sci; 2023 Dec; 38(49):e410. PubMed ID: 38111281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
    Noval Rivas M; Arditi M
    Rheum Dis Clin North Am; 2023 Aug; 49(3):647-659. PubMed ID: 37331738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
    Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergence and divergence in Kawasaki disease and multisystem inflammatory syndrome in children: results from the COVASAKI survey.
    Mastrolia MV; Martini M; Memmini G; Ferrara G; Bernardini R; Peroni D; Consolini R; Marrani E; Agostiniani R; Maccora I; Falorni S; Azzari C; Calabri GB; Pagnini I; Indolfi G; L'Erario M; Trapani S; Simonini G
    Clin Exp Rheumatol; 2024 Apr; 42(4):931-936. PubMed ID: 38683206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.
    Mazori DR; Derrick KM; Kapoor U; Haribhai M; Gist RE; Glick SA
    Pediatr Dermatol; 2021 Jan; 38(1):253-256. PubMed ID: 33222290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease?
    Loke YH; Berul CI; Harahsheh AS
    Trends Cardiovasc Med; 2020 Oct; 30(7):389-396. PubMed ID: 32702413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome.
    Godfred-Cato S; Abrams JY; Balachandran N; Jaggi P; Jones K; Rostad CA; Lu AT; Fan L; Jabbar A; Anderson EJ; Kao CM; Hunstad DA; Rosenberg RB; Zafferani MJ; Ede KC; Ballan W; Laham FR; Beltran Y; Bryant B; Meng L; Hammett TA; Oster ME; Bamrah Morris S; Belay ED
    Pediatr Infect Dis J; 2022 Apr; 41(4):315-323. PubMed ID: 35093995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
    Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
    Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Endothelial Cells: A New Possible Marker of Endothelial Damage in Kawasaki Disease, Multisystem Inflammatory Syndrome in Children and Acute SARS-CoV-2 Infection.
    Fabi M; Petrovic B; Andreozzi L; Corinaldesi E; Filice E; Biagi C; Rizzello A; Mattesini BE; Bugani S; Lanari M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort.
    Yavuz L; AlHamdani S; Alasrawi S; Wafadari D; Al-Fraihat A; Bebars MA; Nath J; Arango D; Pallavidino M; Jain R; Yavuz S; AlAwadhi M; Alkhayat A; Tayoun AA; Abuhammour WM
    Pediatr Rheumatol Online J; 2023 Jun; 21(1):64. PubMed ID: 37386568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
    Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
    Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine profile.
    Fukuda S; Kaneta M; Miyake M; Ohya T; Miyakawa K; Iwamoto M; Ito S
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):442-447. PubMed ID: 33904379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing the differences between multisystem inflammatory syndrome in children and Kawasaki disease.
    Bar-Meir M; Guri A; Godfrey ME; Shack AR; Hashkes PJ; Goldzweig O; Megged O
    Sci Rep; 2021 Jul; 11(1):13840. PubMed ID: 34226639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis.
    Mohsin SS; Abbas Q; Chowdhary D; Khalid F; Sheikh AS; Ali Khan ZG; Aslam N; Bhatti OA; Inam M; Saleem AF; Bhutta AT
    PLoS One; 2021; 16(6):e0253625. PubMed ID: 34153080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease, multisystem inflammatory syndrome in children, and adenoviral infection: a scoring system to guide differential diagnosis.
    Fabi M; Dondi A; Andreozzi L; Frazzoni L; Biserni GB; Ghiazza F; Dajti E; Zagari RM; Lanari M
    Eur J Pediatr; 2023 Nov; 182(11):4889-4895. PubMed ID: 37597046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisystem Inflammatory Syndrome in Children.
    Waseem M; Shariff MA; Lim CA; Nunez J; Narayanan N; Patel K; Tay ET
    West J Emerg Med; 2022 Jul; 23(4):505-513. PubMed ID: 35980407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.